Inventiva SA
PAR:IVA

Watchlist Manager
Inventiva SA Logo
Inventiva SA
PAR:IVA
Watchlist
Price: 2.76 EUR -0.36%
Market Cap: 264m EUR

P/S
Price to Sales

16.9
Current
24.7
Median
7.3
Industry
Lower than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
16.9
=
Market Cap
264m EUR
/
Revenue
15.6m EUR
Revenue Growth P/S to Growth
FR
Inventiva SA
PAR:IVA
Average P/S: 3 322 702.8
16.9
13%
1.3
FR
Pharnext SCA
OTC:PNEXF
36 547 712.8
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
5.1
4%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
4.6
3%
1.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.9
10%
1.2
US
E
Epizyme Inc
F:EPE
1 927.6
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.1
7%
0.7
US
S
Seagen Inc
F:SGT
18.6
30%
0.6
NL
argenx SE
XBRU:ARGX
16.8
37%
0.5

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
38.1
2-Years Forward
P/S
15.2
3-Years Forward
P/S
10.4